Professor, Chair of Pathology, City of Hope Medical Center
Pathology
Dr. Dennis D. Weisenburger, MD
|
|
Give Review
Dennis D. Weisenburger works in the field of Pathology. He went to medical school at University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine He has 3 awards "America's Top Doctors", "Top Doctors:LA Area" and "America's Top Doctors for Cancer". Dennis Weisenburger is a published physician. He has 101 publications published. The most current publication "Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project.
- Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.
- Relationship between ambient ultraviolet radiation and Hodgkin lymphoma subtypes in the United States.
- Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project.
- Non-Hodgkin lymphoma in Romania: a single-centre experience.
- IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
- Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin lymphoma classification project.
- A pooled analysis of cigarette smoking and risk of multiple myeloma from the international multiple myeloma consortium.
- Risk of myeloid neoplasms after solid organ transplantation.
- Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma.
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggresive B-cell lymphoma.
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymph...
- Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
- Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.
- Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Medical History, Lifestyle, Family History, and Occupational Risk Factors for Adult Acute Lymphocytic Leukemia: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Medical history, lifestyle, family history, and occupational risk factors for sporadic burkitt lymphoma/leukemia: the interlymph non-hodgkin lymphoma subtypes project.
- Medical History, Lifestyle, Family History, and Occupational Risk Factors for Peripheral T-Cell Lymphomas: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Medical History, Lifestyle, Family History, and Occupational Risk Factors for Follicular Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project.
- Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
- Clinical and pathologic analysis of extramedullary tumors after hematopoietic stem cell transplantation.
- Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.
- Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care.
- Chronic Lymphocytic Leukemia Cells in Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease.
- Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell lymphoma.
- Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.
- Dietary intake of fruits and vegetables and overall survival in non-Hodgkin lymphoma.
- Relationship Between Rosai-Dorfman Disease and IgG4-Related Disease: Study of 32 Cases.
- Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
- Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
- A Pooled Analysis of Alcohol Consumption and Risk of Multiple Myeloma in the International Multiple Myeloma Consortium.
- Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
- Pre-diagnosis cigarette smoking and overall survival in non-Hodgkin lymphoma.
- B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.
- Risk of lymphoma subtypes after solid organ transplantation in the United States.
- Plasma cell neoplasms in US solid organ transplant recipients.
- microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.
- Dietary patterns and the risk of non-Hodgkin lymphoma.
- Dietary nitrate and nitrite intake and risk of non-Hodgkin lymphoma.
- CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma.
- Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-Cell Lymphoma.
- Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
- Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.
- Phytanic acid and the risk of non-Hodgkin lymphoma.
- Burkitt lymphoma risk in U.S. solid organ transplant recipients.
- Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
- Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
- Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis.
- A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
- Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling.
- Genome-wide MicroRNA profiling of mantle cell lymphoma reveal a distinct subgroup with poor prognosis.
- Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma.
- The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymp...
- Mantle cell lymphoma as a component of composite lymphoma: clinicopathologic parameters and biologic implications.
- Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study.
- Non-Hodgkin lymphoma of the prostate.
- Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach.
- Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.
- MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-Cell Lymphoma Treated with CHOP-like therapy and Rituximab.
- Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
- Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma.
- Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system.
- Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MG...
- Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project.
- Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
- The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab.
- Cooperative epigenetic modulation by cancer amplicon genes.
- InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.
- Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
- Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.
- Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.
- Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
- Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.
- t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.
- A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
- Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.
- Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
- Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report.
- Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
- Adult Burkitt lymphoma: advances in diagnosis and treatment.
- Stromal gene signatures in large-B-cell lymphomas.
- Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family.
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
- Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse la...
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
- Adenocarcinoma of the stomach and esophagus and drinking water and dietary sources of nitrate and nitrite.
- Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma.
- The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma.
- Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic In...
- Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymph...
- Frequent occurrence of deletions in primary mediastinal B-cell lymphoma.
- Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterL...
- Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
- Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
- Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma.
- Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.
- Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma.
- A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus.
Schools
University Of Minnesota Medical School
Ohio State University Hospitals
University Of Iowa Hospitals
City Of Hope
Doctors Specialties
- Pathology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
Education
-
University of Iowa Hospitals and Clinics -
Ohio State University Hospital -
University of Minnesota Medical School
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699727883 |
| Last Name Of The Provider | WEISENBURGER |
| First Name Of The Provider | DENNIS |
| View All |
Similar Doctors
|
|
Dr. Peiguo Chu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yongyi N. Han, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Young Kim, MD |
|
|
Dr. Qin Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bharat Nathwani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Huiqing Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kali L. Freeman, MD
This Doctor is OpenDoctor Recommended.
|